Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms

Part of paid clinical trials in Richmond, Virginia.

Sponsor
OvationLab
Study ID
NCT07720362
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Gastrointestinal
  • Microbiota

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Complete Commensal Probiotic — DIETARY_SUPPLEMENT
    Complete Commensal Probiotic™ contains five established commensal strains selected for their documented physiologic roles in the healthy adult gut. The five commensal strains in the product in this study are Akkermansia muciniphila (TA09), Bifidobacterium adolescentis (TA38), Bifidobacterium longum (TA24), Faecalibacterium prausnitzii (TA35), and Roseburia intestinalis (TA08).

Study Details

A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.

Key Dates

First listed
Jul 22, 2026
Start date
Jul 21, 2026
Status verified
Jul 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Complete Commensal Probiotic

Primary Outcome Measure

Relative Abundance of Commensal Microorganisms [ Time Frame: Baseline and end of 8-week intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OvationLabRichmondVirginia23220
Study Administration
‪(240) 232-2103‬

Find similar trials in Richmond, VA

Related Studies